yvette drew

Associate Professor

The University of British Columbia

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Biology Cancer Biology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

John Lunec

UNITED KINGDOM

View details

Patricia Roxburgh

University of Glasgow

UNITED KINGDOM

View details

Frank Tadashi Zenke

Chief Scientific Officer

SWITZERLAND

View details

Jae-Weon Kim

Professor

Seoul National University Hospital

SOUTH KOREA

View details

David SP Tan

National University of Singapore (NUS)

SINGAPORE

View details

Seock-Ah Im

Professor

Seoul National University College of Medicine

SOUTH KOREA

View details

Ruth Plummer

Clinical Professor

Newcastle University

UNITED KINGDOM

View details

Nicola Curtin

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

yvette drew

Research Interests

Explore related searches

Contact this professor

Articles (8)

Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study

Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling

The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of Response

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors

Tipping Growth Inhibition into Apoptosis by Combining Treatment with MDM2 and WIP1 Inhibitors in p53WT Uterine Leiomyosarcoma

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

Real‐World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10

Collaborators (8)

John Lunec

Patricia Roxburgh

Frank Tadashi Zenke

Jae-Weon Kim

David SP Tan

Seock-Ah Im

Ruth Plummer

Nicola Curtin

Make your next move.